ÃÑ 183ÆäÀÌÁö

2ÆäÀÌÁö º»¹®½ÃÀÛ

Â÷ ·Ê
FMD ¿¬±¸È¸ ¼¼¹Ì³ª ÀÚ·áÁý
1. FMD control program with vaccination and monitoring system in Taiwan¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤ 1
Dr. Shih-Ping Chen (´ë¸¸ ³ó¾÷±â¼ú¿¬±¸¼Ò ¹× ¾çµ·¼öÀÇ»çȸ ȸÀå)
2. Àúº´¿ø¼º ±¸Á¦¿ª ¹ÙÀÌ·¯½ºÀÇ ÀÛ¼º°ú ±× È°¿ë¼º¿¡ ´ëÇÑ °íÂû¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤29
¹ÚÁ¾Çö ¿¬±¸°ü
3. ±¹³» Çѵ· »ê¾÷ ÇöȲ¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤69
Á¤¼±Çö Àü¹«ÀÌ»ç (Çѵ·Çùȸ)
4. ±¸Á¦¿ª ¹é½Å Á¢Á¾°ú NSP Ç×ü »ý¼º°úÀÇ °ü·Ã¼º¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤81
Źµ¿¼· ¿¬±¸°ü
5. General review of major neutralizing epitope of FMD virus and its use
for vaccine development strategy¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤103
ÀÌÁߺ¹ ±³¼ö (°Ç±¹´ëÇб³)
6. Foot and Mouth Disease - Strains, threats and vaccine selection¡¤¡¤¡¤¡¤¡¤115
Dr. Donald King (FAO/OIE ±¸Á¦¿ª Ç¥ÁØ¿¬±¸¼Ò ¼ÒÀå)
7. ÇöÀå¿¡¼­ ¹Ù¶óº» ±¸Á¦¿ª¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤135
À̽ÂÀ± ´ëÇ¥ (ÇѺ°ÆÊÅØ)
[ºÎ·Ï 1] ÇÑ´«¿¡ º¸´Â 2015³â ±¸Á¦¿ªÁø´Ü°ú Çà»ç¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤165
[ºÎ·Ï 2] FMD ¿¬±¸È¸ ȸĢ¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤173

2ÆäÀÌÁö º»¹®³¡



ÇöÀç Æ÷Ä¿½ºÀÇ ¾Æ·¡³»¿ëµéÀº µ¿ÀÏÇÑ ÄÁÅÙÃ÷¸¦ °¡Áö°í ÆäÀÌÁö³Ñ±è È¿°ú¹× ½Ã°¢Àû È¿°ú¸¦ Á¦°øÇÏ´Â ÆäÀÌÁöÀ̹ǷΠ½ºÅ©¸°¸®´õ »ç¿ëÀÚ´Â ¿©±â±îÁö¸¸ ³¶µ¶ÇϽðí À§ÀÇ ÆäÀÌÁöÀ̵¿ ¸µÅ©¸¦ »ç¿ëÇÏ¿© ´ÙÀ½ÆäÀÌÁö·Î À̵¿ÇϽñ⠹ٶø´Ï´Ù.
»ó´Ü¸Þ´º ¹Ù·Î°¡±â ´ÜÃàÅ°¾È³» : ÀÌÀüÆäÀÌÁö´Â ÁÂÃø¹æÇâÅ°, ´ÙÀ½ÆäÀÌÁö´Â ¿ìÃø¹æÇâÅ°, ùÆäÀÌÁö´Â »ó´Ü¹æÇâÅ°, ¸¶Áö¸·ÆäÀÌÁö´Â ÇϴܹæÇâÅ°, ÁÂÃøÈ®´ëÃà¼Ò´Â insertÅ°, ¿ìÃøÈ®´ëÃà¼Ò´Â deleteÅ°